Article
Genetic and Phenotypic Profiling of Triptan Users in a Swedish Cluster Headache Cohort.
Journal of molecular neuroscience : MN - 18 Apr 2024
Jennysdotter Olofsgård Felicia, Ran Caroline, Qin Yuyan, Fourier Carmen, Waldenlind Elisabet, Steinberg Anna, Sjöstrand Christina, Belin Andrea Carmine
Abstract excerpt
Up to 25% of individuals who live with cluster headache (CH), an extremely painful primary headache disorder, do not adequately respond to the first-line treatment, triptans. Studies have indicated that genetic variants can play a role in treatment response. Likewise, differences in clinical characteristics can give clues to mechanisms underlying triptan non-response. Our aim was to investigate five genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
